3/12
07:38 am
rckt
Rocket Pharmaceuticals, Inc. (NASDAQ: RCKT) is now covered by analysts at BMO Capital Markets. They set an "outperform" rating and a $50.00 price target on the stock.
Medium
Report
Rocket Pharmaceuticals, Inc. (NASDAQ: RCKT) is now covered by analysts at BMO Capital Markets. They set an "outperform" rating and a $50.00 price target on the stock.
3/12
05:04 am
rckt
Rating for RCKT
Low
Report
Rating for RCKT
3/12
05:04 am
rckt
Rating for RCKT
Low
Report
Rating for RCKT
3/11
04:17 pm
rckt
Rocket Pharmaceuticals initiated with an Outperform at BMO Capital
Medium
Report
Rocket Pharmaceuticals initiated with an Outperform at BMO Capital
3/11
04:17 pm
rckt
Rocket Pharmaceuticals initiated with an Outperform at BMO Capital
Medium
Report
Rocket Pharmaceuticals initiated with an Outperform at BMO Capital
3/3
10:02 am
rckt
Rating for RCKT
Medium
Report
Rating for RCKT
3/3
10:02 am
rckt
Rating for RCKT
Medium
Report
Rating for RCKT
3/3
09:59 am
rckt
Rating for RCKT
Low
Report
Rating for RCKT
3/3
09:59 am
rckt
Rating for RCKT
Low
Report
Rating for RCKT
3/3
09:59 am
rckt
Rating for RCKT
Low
Report
Rating for RCKT
3/3
07:36 am
rckt
Rating for RCKT
Medium
Report
Rating for RCKT
2/28
10:18 am
rckt
Rating for RCKT
Low
Report
Rating for RCKT
2/28
07:24 am
rckt
Rating for RCKT
Report
Rating for RCKT
2/28
07:24 am
rckt
Rating for RCKT
Report
Rating for RCKT